Is low dose Tranexamic acid less effective than a standard dose at reducing blood loss and inhibiting hyperfibrinolysis in hemorrhagic caesarean section? Multicenter double–blind placebo-controlled dose-ranging (TRACES) trial.
- DOI
- 10.22541/au.163584601.19864996/v1
- Published
- 2021-11-02
- Container
- Not recorded
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.22541/au.163584601.19864996/v1,
title = {Is low dose Tranexamic acid less effective than a standard dose at reducing blood loss and inhibiting hyperfibrinolysis in hemorrhagic caesarean section? Multicenter double–blind placebo-controlled dose-ranging (TRACES) trial.},
author = {Ducloy-Bouthors A and Gilliot S and Kyheng M and Faraoni D and Turbelin A and Keita H and Rigouzzo A and Moyanotidou G and Constant B and Broisin F and Le-Gouez A and Favier R and Peynaud E and Ghesquiere l and Lebuffe G and Duhamel A and Allorge D and Susen S and Hennart B and Jeanpierre E and Odou P.},
year = {2021},
doi = {10.22541/au.163584601.19864996/v1},
url = {https://doi.org/10.22541/au.163584601.19864996/v1}
}RIS
TY - JOUR TI - Is low dose Tranexamic acid less effective than a standard dose at reducing blood loss and inhibiting hyperfibrinolysis in hemorrhagic caesarean section? Multicenter double–blind placebo-controlled dose-ranging (TRACES) trial. AU - Ducloy-Bouthors A AU - Gilliot S AU - Kyheng M AU - Faraoni D AU - Turbelin A AU - Keita H AU - Rigouzzo A AU - Moyanotidou G AU - Constant B AU - Broisin F AU - Le-Gouez A AU - Favier R AU - Peynaud E AU - Ghesquiere l AU - Lebuffe G AU - Duhamel A AU - Allorge D AU - Susen S AU - Hennart B AU - Jeanpierre E AU - Odou P. PY - 2021 DO - 10.22541/au.163584601.19864996/v1 UR - https://doi.org/10.22541/au.163584601.19864996/v1 ER -
APA
A, D., S, G., M, K., D, F., A, T., H, K., A, R., G, M., B, C., F, B., A, L., R, F., E, P., l, G., G, L., A, D., D, A., S, S., B, H., E, J., & P., O. (2021). Is low dose Tranexamic acid less effective than a standard dose at reducing blood loss and inhibiting hyperfibrinolysis in hemorrhagic caesarean section? Multicenter double–blind placebo-controlled dose-ranging (TRACES) trial.. https://doi.org/10.22541/au.163584601.19864996/v1
Source records
- europe-pmc · retrieved 2026-09-26T03:11:54.049Z